Ledger.Open graph →
SEC Form D · Amendment · filed January 29, 2014

Reven Pharmaceuticals, Inc

Offering
$2.0M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SARASOTA, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Michael B. Handley · Sarasota, FLExecBrian B. Denomme · Sarasota, FLExec · DirectorPeter B. Lange · Sarasota, FLExec · DirectorJeffrey R. Brown · New York, NYExec · DirectorTeresa K. Hassara · New York, NYExecEdward M. Hundert · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗